# Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

> **NCT00249873** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 7554 (actual)

## Conditions studied

- Atrial Fibrillation
- Vascular Risk

## Interventions

- **DRUG:** clopidogrel (SR25990C)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00249873
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 7554 (ACTUAL)
- **Last updated:** 2015-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249873, "Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00249873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*